StockWatch
·
Pharmaceuticals
ESG10 Oct 2026, 06:30 pm

Solara's ESG Rating Upgraded to Crisil ESG 63 (Strong)

AI Summary

Solara Active Pharma Sciences Ltd. announced it received an ESG Rating of Crisil ESG 63 under the 'Strong' category for Fiscal 2026 (period ended March 31, 2026). This marks an upgrade from Crisil ESG 56 for the period ended March 31, 2025. The rating was independently assigned by Crisil ESG Ratings & Analytics Limited, a SEBI registered Category 1 ESG rating provider, based on the company's disclosures for FY2026 and other publicly available information. Solara did not engage Crisil ESG Ratings for this assessment.

Key Highlights

  • Solara received Crisil ESG 63 rating for FY2026.
  • Rating upgraded to 'Strong' from Crisil ESG 56 (FY2025).
  • Crisil ESG Ratings independently assigned the assessment.
  • Rating based on company disclosures and public information.